John Coia
- Endocrinology top 0.5%
- Escherichia coli research studies 15
- Infectious Diseases top 0.5%
- Viral gastroenteritis research and epidemiology 21
- Clostridium difficile and Clostridium perfringens research 21
- Antimicrobial Resistance in Staphylococcus 15
- Infection Control in Healthcare 11
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 14
- Molecular Medicine top 1%
-
- Salmonella and Campylobacter epidemiology 20
-
- Microscopic Colitis 9
John Coia
102 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Endocrinology 760
- Infectious Diseases 2.0k
- Applied Microbiology and Biotechnology 177
- Clinical Biochemistry 446
- Molecular Medicine 308
Countries citing papers authored by John Coia
This map shows the geographic impact of John Coia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Coia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Coia more than expected).
Fields of papers citing papers by John Coia
This network shows the impact of papers produced by John Coia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Coia. The network helps show where John Coia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Coia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 11 | |
| 11 | European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adultsbreakdown → | 2021 | 354 |
| 12 | 2019 | 49 | |
| 13 | 2016 | 86 | |
| 14 | Use of respiratory and facial protection. | 2014 | 1 |
| 15 | 2013 | 104 | |
| 16 | 2011 | 12 | |
| 17 | 2010 | 87 | |
| 18 | 2008 | 77 | |
| 19 | 2007 | 37 | |
| 20 | Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting | 2001 | 2 |
About John Coia
John Coia is a scholar working on Endocrinology, Infectious Diseases, Clinical Biochemistry, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 104 papers that have together received 3.8k indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (21 papers), Clostridium difficile and Clostridium perfringens research (21 papers), Salmonella and Campylobacter epidemiology (20 papers), Antimicrobial Resistance in Staphylococcus (15 papers), Escherichia coli research studies (15 papers), Bacterial Identification and Susceptibility Testing (14 papers), Infection Control in Healthcare (11 papers) and Microscopic Colitis (9 papers). The work is most often cited by research in Endocrinology (760 citations), Infectious Diseases (2.0k citations), Applied Microbiology and Biotechnology (177 citations), Clinical Biochemistry (446 citations) and Molecular Medicine (308 citations). John Coia has collaborated with scholars based in United Kingdom, Denmark and Ireland. Frequent co-authors include Carole Fry, J.G. Anderson, H. Humphreys, S.J. MacGregor, David Edwards, M. Farrington, C. Mallaghan, G. Duckworth, D.R. Tucker and Derek Brown. Their work appears in journals such as Journal of Hospital Infection, Journal of Medical Microbiology, Eurosurveillance, Journal of Infection and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.